PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹55 Cr | ₹33 Cr | ₹38 Cr | ₹136 Cr | ₹85 Cr |
What is the latest Total Non-Current Liabilities ratio of PFIZER ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹55 Cr |
Mar2024 | ₹33 Cr |
Mar2023 | ₹38 Cr |
Mar2022 | ₹136 Cr |
Mar2021 | ₹85 Cr |
How is Total Non-Current Liabilities of PFIZER Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹55 Cr | 67.65 | |
Mar2024 | ₹33 Cr | -14.76 | |
Mar2023 | ₹38 Cr | -71.81 | |
Mar2022 | ₹136 Cr | 60.16 | |
Mar2021 | ₹85 Cr | - |
Compare Total Non-Current Liabilities of peers of PFIZER
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PFIZER | ₹23,508.8 Cr | -0.3% | 0.5% | -15.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹379,191.0 Cr | 2% | -2.3% | -12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,973.0 Cr | -1.3% | -6.2% | 21.2% | Stock Analytics | |
CIPLA | ₹124,507.0 Cr | -2.2% | 3.6% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,175.0 Cr | -0% | -0.3% | 5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,355.0 Cr | -0.9% | 4.5% | -8.6% | Stock Analytics |
PFIZER Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PFIZER | -0.3% |
0.5% |
-15.9% |
SENSEX | 1.1% |
-0.4% |
-2.2% |
You may also like the below Video Courses